Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Aethlon Medical, Inc. AEMD
$0.32
+$0.01 (2.01%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
7442053.00000000
-
week52high
2.46
-
week52low
0.23
-
Revenue
294165
-
P/E TTM
-1
-
Beta
1.18131400
-
EPS
-0.67000000
-
Last Dividend
0.00000000
-
Next Earnings Date
26 июн 2023 г. в 20:15
Описание компании
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 25 июн 2021 г. |
| HC Wainwright & Co. | Buy | 01 июн 2021 г. | |
| Maxim Group | Buy | 08 янв 2021 г. | |
| H.C. Wainwright | Buy | 25 ноя 2020 г. | |
| H.C. Wainwright | Buy | 20 ноя 2017 г. | |
| Maxim Group | Hold | Buy | 15 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Arnold Lee D | A | 60620 | 60620 | 01 февр 2023 г. |
| BROENNIMAN EDWARD G | D | 59359 | 3425 | 30 дек 2022 г. |
| Shah Chetan | D | 50039 | 3425 | 30 дек 2022 г. |
| Shah Chetan | D | 53464 | 6849 | 30 сент 2022 г. |
| BROENNIMAN EDWARD G | D | 62784 | 6849 | 30 сент 2022 г. |
| Rossetti Angela | A | 51370 | 51370 | 15 сент 2022 г. |
| BROENNIMAN EDWARD G | A | 69633 | 34247 | 15 сент 2022 г. |
| Shah Chetan | A | 60313 | 34247 | 15 сент 2022 г. |
| JOHNSON SABRINA MARTUCCI | D | 33642 | 2430 | 31 мар 2022 г. |
| Shah Chetan | D | 26066 | 2430 | 31 мар 2022 г. |
Новостная лента
5 Hot Penny Stocks To Watch With The Stock Market Down This Week
PennyStocks
24 апр 2023 г. в 13:15
Hot penny stocks to watch this week. This is a significant week for earnings, and mega-cap tech names will headline what's sure to be a volatile week. Next week, the action continues with the upcoming Fed meeting and another rate hike decision.
Essential Penny Stock Trading Tools: Maximizing Efficiency
PennyStocks
21 апр 2023 г. в 06:00
Use these tips for trading penny stocks efficiently The post Essential Penny Stock Trading Tools: Maximizing Efficiency appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Aethlon Medical, Inc. (AEMD) Q3 2023 Earnings Call Transcript
Seeking Alpha
13 февр 2023 г. в 18:37
Aethlon Medical, Inc. (NASDAQ:AEMD ) Q3 2023 Earnings Conference Call February 13, 2023 4:30 PM ET Company Participants Jim Frakes - Chief Financial Officer Steven LaRosa - Chief Medical Officer Guy Cipriani - Chief Business Officer Conference Call Participants Marla Marin - Zacks Anthony Vendetti - Maxim Group Operator Good day, and welcome to the Aethlon Medical Third Quarter Fiscal 2023 Earnings and Corporate Update Call. All participants will be in listen-only mode.
Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 13, 2023
PRNewsWire
06 февр 2023 г. в 08:01
SAN DIEGO , Feb. 6, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its third quarter ended December 31, 2022, at 4:15 p.m. EST on Monday, February 6, 2023.
Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023
PRNewsWire
31 янв 2023 г. в 08:01
Presentation on Thursday, February 2nd, 2023 at 10:00 AM ET SAN DIEGO , Jan. 31, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, announced today that it will be presenting virtually at the upcoming Sequire Biotechnology Conference on Thursday, February 2nd, at 10:00 AM ET. Steven LaRosa, M.D.